The COVID-19 pandemic revealed global healthcare system vulnerabilities and societal impacts (1). Many countries experienced disruptions in health service delivery, exacerbating challenges in essential health services, human resources, and medical supply allocation (2, 3). As such, enhanced capabili

The UK National Institute for Health and Clinical Excellence (NICE) is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health. With an annual budget of approximately £35 million, NICE employs 250 staf

Historical development of health technology assessment in Thailand Teerawattananon Y*, Tantivess S*, Yothasamut J*, Kingkaew P *, Chaisiri K*. *Health Intervention and Technology Assessment Program, Thailand Objectives This study aims to review the development of health technology assessme

Setting priorities for health interventions in developing countries: a review of empirical studies. Sitaporn Youngkong 1,2 Lydia Kapiriri 3 Rob Baltussen 1 1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of Primary and Community Care, Radboud Universit

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4 1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands 2 Health I

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP),